The Serpin α1-Proteinase Inhibitor Is a Critical Substrate for Gelatinase B/MMP-9 In Vivo
Top Cited Papers
Open Access
- 1 September 2000
- journal article
- research article
- Published by Elsevier
- Vol. 102 (5) , 647-655
- https://doi.org/10.1016/s0092-8674(00)00087-8
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- A critical role for neutrophil elastase in experimental bullous pemphigoidJournal of Clinical Investigation, 2000
- Gelatinase B–deficient Mice Are Resistant to Experimental Bullous PemphigoidThe Journal of Experimental Medicine, 1998
- The autoimmune blistering skin disease bullous pemphigoid. The presence of plasmin/alpha 2-antiplasmin complexes in skin blister fluid indicates plasmin generation in lesional skin.Journal of Clinical Investigation, 1993
- Enhanced association of plasminogen/plasmin with lesional epidermis of bullous pemphigoidBritish Journal of Dermatology, 1992
- Inactivation of human plasma α1‐proteinase inhibitor by human PMN leucocyte collagenaseFEBS Letters, 1990
- Tissue Destruction by NeutrophilsNew England Journal of Medicine, 1989
- The inhibitory complex of human alpha 1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractant.The Journal of Experimental Medicine, 1988
- Elevated Levels of Human Collagenase Inhibitor in Blister Fluids of Diverse EtiologyJournal of Investigative Dermatology, 1986
- Demonstration of Collagenase and Elastase Activities in the Blister Fluids from Bullous Skin Diseases. Comparison Between Dermatitis Herpetiformis and Bullous PemphigoidJournal of Investigative Dermatology, 1983
- Isolation and properties of oxidized alpha-1-proteinase inhibitor from human rheumatoid synovial fluidBiochemical and Biophysical Research Communications, 1980